Sitah Mohammed Alotaibi

Ms. Sitah Mohammed Alotaibi

College of Nursing, Princess Nourah bint Abdulrahman University, Riyadh, Ar Riyāḑ, Saudi Arabia
orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
AJAzzam Zohair Jad
Azzam Zohair Jad
SASitah Mohammed Alotaibi
Sitah Mohammed Alotaibi
AAAmjad Asiri
Amjad Asiri
SAShouq Khalid Alobaid
Shouq Khalid Alobaid
RGRana Al Gahamdi
Rana Al Gahamdi
Abdullah AlmaqhawiAbdullah Almaqhawi
Abdullah Almaqhawi
Background: Missed primary care appointments disrupt continuity, reduce care quality, and increase healthcare costs. Despite numerous studies, global patterns and predictors of appointment non-adherence remain inconsistently reported. Objective: To identify, categorize, and evaluate the consistency of predictors of appointment non-adherence in primary care across diverse populations and healthcare systems. Methods: A systematic review was conducted following PRISMA guidelines (PROSPERO ID: CRD420251121963). PubMed/MEDLINE, Scopus, Web of Science, and Cochrane were searched in August 2025 for observational studies examining predictors of missed, canceled, or rescheduled primary care appointments. Study quality was appraised using the MINORS tool. Results: Twenty-seven observational studies (1982–2025) across eight countries were included, representing a total of more than 13 million appointments analyzed. Reported non-attendance varied widely (~5–31%). Predictors clustered into: patient-level (younger age, socioeconomic disadvantage, minority status in North American studies, mental health burden, and lower literacy/greater social needs), appointment-level (prior non-attendance and longer time between booking and visit), and clinic/system-level (access barriers such as transportation and scheduling friction). Telemedicine and continuity with the same clinician were associated with lower non-attendance in more recent studies. Due to heterogeneity in definitions and analyses, the results were synthesized narratively; overall study quality was modest–moderate by MINORS. Conclusions: Missed appointments reflect interacting patient- and system-level determinants, with the highest risk among younger and socioeconomically disadvantaged patients and those with mental health conditions. Interventions that reduce access friction (e.g., reminders, flexible scheduling/shorter lead times, transportation support) and equity-focused hybrid telemedicine may reduce non-adherence.

29 March 2026 in Vaccines
Verified
Journal Article
Open access
PDF file
SASitah Mohammed Alotaibi
Sitah Mohammed Alotaibi
MBMazen Bostaji
Mazen Bostaji
AAAnas Alharbi
Anas Alharbi
LALatifa Alaqeel
Latifa Alaqeel
GAGhaida Alsharif
Ghaida Alsharif
Abdullah AlmaqhawiAbdullah Almaqhawi
Abdullah Almaqhawi
Background: Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide, and seasonal influenza is a recognized trigger of acute cardiovascular events. The influenza vaccine has been proposed as a secondary preventative measure, though the benefits regarding mortality and cardiovascular events are unclear. Objective: This study aimed to establish the efficacy of influenza vaccination in lowering mortality and major cardiovascular events in adults suffering from established CVD. Methods: A systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted. Eligible studies were identified from PubMed, Google Scholar, and The Cochrane Central Register of Controlled Trials (CENTRAL) through November 2025. RCTs involving adults with established CVD evaluating influenza vaccine impact in comparison to placebo or standard care were included. The Cochrane Risk of Bias tool 2 was used to evaluate study quality. Results: A total of eight RCTs met the inclusion criteria. Influenza vaccination was associated with a statistically significant decrease in the composite outcome (of all-cause mortality, acute myocardial infarction, and stent thrombosis) (OR 0.71, 95% CI 0.57–0.90; p = 0.004; I2 = 0%) and major adverse cardiovascular events (OR 0.44, 95% CI 0.26–0.74; p = 0.002; I2 = 0%). Cardiovascular mortality was found to be significantly lower in the vaccination group (OR 0.64, 95% CI 0.47–0.86; p = 0.003). However, all-cause mortality was not significantly reduced (OR 1.13, 95% CI 0.79–1.62; p = 0.50; I2 = 88%). Conclusions: Influenza vaccination was associated with a reduction in combined cardiovascular events and mortality due to cardiovascular causes in adults diagnosed with established CVD. In contrast, all-cause mortality was not significantly reduced, and the evidence for this outcome was inconclusive. This supports the routine use of the vaccine as an adjunctive measure in the secondary prevention of CVD.